Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹6 Cr
Revenue (TTM)
₹160 Cr
Net Profit (TTM)
₹3 Cr
ROE
2.1 %
ROCE
11.6 %
P/E Ratio
--
P/B Ratio
--
Industry P/E
44.74
EV/EBITDA
12
Div. Yield
0 %
Debt to Equity
0.8
Book Value
₹--
EPS
₹-0.8
Face value
1
Shares outstanding
244,459,983
CFO
₹-14.70 Cr
EBITDA
₹230.48 Cr
Net Profit
₹93.58 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Ameya Laboratories
| -4.0 | 20.0 | -11.1 | -11.1 | -49.6 | -48.9 | -- |
|
BSE Sensex*
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
BSE Healthcare#
| -4.7 | -5.8 | -5.4 | 1.3 | 23.7 | 14.0 | 10.6 |
|
Company
|
2014
|
|---|---|
|
Ameya Laboratories
| -3.8 |
|
BSE Sensex
| 29.9 |
|
BSE Healthcare
| 47.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Ameya Laboratories
|
0.2 | 5.9 | 160.4 | -19.8 | 2.9 | -12.4 | -- | -- |
| 2,110.2 | 17,282.6 | 1,215.1 | 284.8 | 28.7 | 21.1 | 60.2 | 11.4 | |
| 656.2 | 12,893.6 | 7,266.8 | 627.5 | 11.9 | 12.6 | 20.5 | 2.4 | |
| 613.6 | 15,214.7 | 5,092.5 | 545.5 | 15.9 | 14.1 | 27.9 | 3.7 | |
| 839.3 | 13,375.6 | 7,918.4 | 429.9 | 10.7 | 7.2 | 30.9 | 2.0 | |
| 1,027.6 | 18,409.8 | 4,560.2 | 1,544.6 | 35.1 | 19.2 | 11.8 | 2.1 | |
| 1,404.5 | 16,092.2 | 1,419.3 | 20.1 | 8.4 | 0.5 | 800.5 | 2.8 | |
| 142.2 | 18,882.0 | 8,871.4 | -223.5 | 1.9 | -1.6 | -- | 2.4 | |
| 391.1 | 15,752.9 | 3,720.2 | 352.1 | 13.7 | 8.2 | 44.7 | 3.3 | |
| 1,271.5 | 20,670.6 | 3,151.0 | -10.0 | 8.4 | 2.5 | 939.6 | 4.5 |
No Review & Analysis are available.
Manufacture of allopathic pharmaceutical preparations
Incorporated
1996
Chairman
--
Managing Director
K Hari Babu
Headquarters
Hyderabad, Andhra Pradesh
Website
Looking for more details about Ameya Laboratories Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View AnnouncementsBoard Meeting Intimation for Results
17-Mar-2017Board Meeting Intimation for Results
02-Mar-2017
The share price of Ameya Laboratories Ltd is ₹0.24 (BSE) as of 16-Mar-2015 IST. Ameya Laboratories Ltd has given a return of -49.56% in the last 3 years.
Since, TTM earnings of Ameya Laboratories Ltd is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2012
|
12.44
|
0.26
|
|
2011
|
5.74
|
0.48
|
|
2010
|
7.52
|
1.03
|
|
2009
|
0.97
|
2.27
|
|
2008
|
0.00
|
0.00
|
The 52-week high and low of Ameya Laboratories Ltd are Rs -- and Rs -- as of 03-Apr-2026.
Ameya Laboratories Ltd has a market capitalisation of ₹ 6 Cr as on 16-Mar-2015. As per SEBI classification, it is a company.
Before investing in Ameya Laboratories Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.